Effect of deflazacort and prednisone versus placebo on pulmonary function in boys with Duchenne muscular dystrophy who have lost ambulation

被引：0
|
作者：
Dubow, J. [1 ]
Cunniff, T. [1 ]
Wanaski, S. [1 ]
Meyer, J. [1 ]
机构：
[1] Marathon Pharmaceut, Northbrook, IL USA
来源：
NEUROMUSCULAR DISORDERS | 2016年 / 26卷
关键词：
D O I：
10.1016/j.nmd.2016.06.339
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.310
引用
收藏
页码：S179 / S180
页数：2
相关论文
共 45 条
  • [21] Integrated prospective results from the deflazacort clinical program suggest less severe psychiatric adverse events with deflazacort versus prednisone in Duchenne muscular dystrophy
    Dubow, J.
    Sazani, P.
    Cunniff, T.
    Wanaski, S.
    Meyer, J.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S180 - S180
  • [22] ATALUREN DELAYS LOSS OF AMBULATION AND DECLINE IN PULMONARY FUNCTION IN PATIENTS WITH NONSENSE MUTATION DUCHENNE MUSCULAR DYSTROPHY
    McDonald, Craig
    Muntoni, Francesco
    Rance, Mark
    Jiang, Joel
    Kristensen, Allan
    Penematsa, Vinay
    Bibbiani, Francesco
    Goodwin, Elizabeth
    Gordish-Grossman, Heather
    Morgenroth, Lauren
    Able, Richard
    Trifillis, Panayiota
    Souza, Marcio
    Tulinius, Mar
    MUSCLE & NERVE, 2020, 62 : S53 - S54
  • [23] Ataluren delays loss of ambulation and decline in pulmonary function in patients with nonsense mutation Duchenne muscular dystrophy
    McDonald, C.
    Muntoni, F.
    Rance, M.
    McIntosh, J.
    Jiang, J.
    Kristensen, A.
    Penematsa, V.
    Bibbiani, F.
    Goodwin, E.
    Gordish-Dressman, H.
    Morgenroth, L.
    Trifillis, P.
    Souza, M.
    Tulinius, M.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S132 - S132
  • [24] Long term daily prednisone therapy delays loss of ambulation and decline in pulmonary function in patients with Duchenne dystrophy
    Pandya, S
    Moxley, RT
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 : S120 - S120
  • [25] Effect of pulmonary function on right heart function in Duchenne muscular dystrophy patients
    Sharath Subramanian
    Kan N Hor
    Wojciech Mazur
    Suzanne Smart
    Tam Tran
    Nancy Halnon
    Michael D Taylor
    Linda Cripe
    Subha V Raman
    Journal of Cardiovascular Magnetic Resonance, 17 (Suppl 1)
  • [26] Audit of DEXA bone density scans in boys with Duchenne muscular dystrophy who have sustained fractures
    Willis, T.
    Emery, N.
    Kulshrestha, R.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S196 - S197
  • [27] Functional trajectories of upper limb and pulmonary function before and after loss of ambulation in Duchenne muscular dystrophy
    Goemans, N.
    Signorovitch, J.
    McDonald, C.
    Mercuri, E.
    Niks, E.
    Wong, B.
    Sajeev, G.
    Fillbrunn, M.
    Yim, E.
    Dieye, I.
    Ward, S.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S86 - S86
  • [28] Ataluren Delays Loss of Ambulation and Decline in Pulmonary Function in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
    McDonald, Craig
    Muntoni, Francesco
    Rance, Mark
    Jiang, Joel
    Kristensen, Allan
    Penematsa, Vinay
    Bibbiani, Francesco
    Goodwin, Elizabeth
    Gordish-Dressman, Heather
    Morgenroth, Lauren
    Able, Richard
    Trifillis, Panayiota
    Tulinius, Mar
    NEUROLOGY, 2021, 96 (15)
  • [29] The effect of corticosteroid treatment on pulmonary function in adults with Duchenne muscular dystrophy
    Pietrusz, A.
    Astin, R.
    Guglieri, M.
    Desikan, M.
    Waller, K.
    Chapman, S.
    Schiava, M.
    Brady, S.
    Soleimani, B.
    Freebody, J.
    Nickol, A.
    Ramdharry, G.
    Muntoni, F.
    Quinlivan, R.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S106 - S107
  • [30] Does steroid therapy influence pulmonary function decline in adults with Duchenne muscular dystrophy after loss of ambulation?
    Pietrusz, A.
    Astin, R.
    Ramdharry, G.
    Quinlivan, R.
    Desikan, M.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S132 - S132
12345